Skip to main content
Mdm2

Mdm2

ProteinWikipedia

Search complete. 5 mentions across 3 episodes found for "Mdm2".

Sep 18, 2026

Lisa TamatiHOST
48:04
The seventh area that we look at is DNA protection and repair, and this is the one people understand least, and I think it's quietly one of the most important.
Lisa TamatiHOST
48:13
The TP53, the tumor suppressor, sometimes called the guardian of the genome, And then there's ATM, MLH1, MDM2, XRCC3, plus the antioxidant genes that we talked about before, those combination of three.
Lisa TamatiHOST
48:30
SOD2, SOD3, GPX1 and catalase.
Lisa TamatiHOST
48:33
And what this section tells you is how well your cells repair the damage that happens to them every single day and how well you mop up the oxidative stress that can cause the damage in the first place.
Neeta SomaiahGUEST
15:54
And the pathologist usually will run certain panels.
Neeta SomaiahGUEST
15:57
You know, they might do a FISH for MDM2 or they might do some PCR or they might run a fusion panel for diagnostic purposes.
Neeta SomaiahGUEST
16:04
So that is important because that helps us know what the chemosensitivity is.
Neeta SomaiahGUEST
16:11
might be, or radiation sensitivity in some cases.

10 MINS LATER

Neeta SomaiahGUEST
26:15
Didn't pan out for all of those subtypes.
Neeta SomaiahGUEST
26:18
And then you also have a lot that we see a lot of copy number alterations.
Neeta SomaiahGUEST
26:24
So, for example, the well-differentiated, de-differentiated liposarcoma will fall under that, that even though it's a spectrum of low-grade to high-grade disease, all of them have MDM2, and majority of them will have CDK4 that is amplified.
Neeta SomaiahGUEST
26:38
Multiple gene copies, not mutated, but it's an early amplification of this chromosome 12, a portion of chromosome 12.
John MascarenhasGUEST
10:23
Most definitely.
John MascarenhasGUEST
10:24
So, for example, NAV2 is an oral MDM2 inhibitor that activates P53.
John MascarenhasGUEST
10:29
Very active agent.
John MascarenhasGUEST
10:30
Has activity as a single agent in the relapse refractory setting.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.